2015 Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coron

19 Pages·2015·1.22 MB·English

1

Protective efficacy of recombinant Modified Vaccinia virus Ankara (MVA) delivering
1

Middle East Respiratory Syndrome coronavirus spike glycoprotein
2

3

4

Asisa Volz1, Alexandra Kupke2, Fei Song1, Sylvia Jany1, Robert Fux1, Hosam Shams-Eldin2,
5

Jörg Schmidt2, Christin Becker3, Markus Eickmann2, Stephan Becker2, and Gerd Sutter1 #
6

7

1German Centre for Infection Research (DZIF), Institute for Infectious Diseases and
8

Zoonoses, LMU University of Munich, Munich, Veterinaerstrasse 13, D-80539 Munich,
9

Germany;
10

2German Centre for Infection Research (DZIF), Institute of Virology, Philipps University
11

Marburg, Marburg, Germany;
12

3University of Giessen Lung Center, Department of Internal Medicine II, Section of Infectious
13

Diseases, Giessen, Germany;
14

15

Running title: Protective immunization with MVA-MERS-S vaccine
16

17

Abstract: 75 words
18

Text: 1202 words
19

20

#corresponding author: